AnalystBro Research
Research
Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.
10 articles.
Bangladesh All Bangladesh research →
Company · DSE:UCB · Banks · Analysis · 03 Nov 2026
United Commercial Bank: 15.5% NPL and a Tk5,595 crore provision shortfall that Bangladesh Bank let it leave out of the 2025 accounts
UCB's auditor qualified the 2025 accounts: required provisions of BDT 76.8bn, BDT 25.2bn held; CRAR of 8.42% with 12.5% required, and 0.93% had the shortfall been booked. Deposits grew 23% in 2025, interest paid took 95% of interest income in the first nine months of 2026, and the shares sit in the Z category after two years without a dividend.
Company · DSE:SBACBANK · Banks · Analysis · 03 Nov 2026
SBAC Bank: NPL of 19.9%, a BDT 10.2bn provision shortfall deferred by Bangladesh Bank, and a qualified 2025 audit
Classified loans rose from 5.9% of loans in 2023 to 19.9% at Dec-2025; the bank kept BDT 3.3bn of a BDT 13.6bn required provision under a BB deferral, the auditor qualified its opinion, profit fell to BDT 7m and the shares moved to DSE's Z category in April 2026.
Company · DSE:ISLAMIBANK · Banks (Islamic) · Analysis · 02 Nov 2026
Islami Bank Bangladesh: 49.65% of investments classified and a BDT 846.2bn provision shortfall; bank equity BDT 69.6bn
Classified investments reached BDT 943.2bn at December 2025, and Bangladesh Bank permitted the bank to finalise its 2025 accounts without the BDT 846.2bn provision adjustment. CRAR is 6.42%, deposits fell 8.8% in the nine months to September 2026, Bangladesh Bank took a series of board actions and the shares moved to the Z category.
Company · DSE:CENTRALPHL · Pharmaceuticals & healthcare · Analysis · 31 Oct 2026
Central Pharmaceuticals: adverse audit opinion on FY2025, turnover of BDT 33.1m and sponsors at 7.67%
A Z-category DSE drug maker with one factory in Mirpur, Dhaka: seven years of filings, an auditor's adverse opinion on the FY2025 accounts, BDT 268.5m of Janata Bank loans carried without change since before June 2022, and FY2026 results announced on 27-Oct-2026.
Company · DSE:DACCADYE · Textiles: home-textile weaving, dyeing and printing · Analysis · 31 Oct 2026
Dacca Dyeing: frozen bank loans of BDT 1,252m, a qualified FY2025 audit with a going-concern paragraph, and NAV per share of BDT (18.23) at March 2026
A Tongi home-textile mill: dyeing and printing output was 10.5% of installed capacity in FY2025 (derived); Titas Gas disconnected its gas on 26-Jul-2023; NAV per share was BDT (16.99) at 31-Dec-2025 after the company recognised additional bank interest (DSE 1-Feb-2026).
Company · DSE:ALLTEX · Textiles: woven fabric dyeing and printing (home textile) · Analysis · 31 Oct 2026
Alltex Industries: a qualified FY2025 audit, BDT 3,075m of bank loans against BDT 379.5m of turnover, and FY2026 EPS of BDT 0.27
A Rupganj home-textile dyeing and printing mill that used 1.11% of its stated capacity in FY2025 and had no export sales; Bangladesh Bank re-fixed its loans at three banks in 2025 and the auditor qualified the accounts on going concern and loan interest.
Company · DSE:BPML · Plastics, packaging & paper · Analysis · 31 Oct 2026
Bashundhara Paper Mills: revenue fell 54% in FY2025, finance costs reached BDT 3.8bn and NAV per share fell to BDT 7.09 by June 2026
FY2025 revenue was BDT 6.04bn against BDT 13.16bn, the loss was BDT 3.30bn, and the DSE-announced FY2026 loss per share is BDT 42.74; borrowings were BDT 29.9bn at March 2026.
Company · DSE:AAMRANET · IT services and ISPs · Analysis · 29 Oct 2026
aamra networks: FY2025 audit opinion qualified; FY2026 EPS BDT (0.80) after BDT 0.13 in FY2025 and BDT 2.46 in FY2024
Revenue fell from BDT 1,214.1m in FY2024 to BDT 921.5m in FY2025 and BDT 558.5m in the nine months to March 2026 (-22.1%); Z category since 12-Feb-2025; advances to suppliers and others BDT 728.7m at 31-Mar-2026; 0.20% cash dividend for general shareholders for FY2026.
Company · DSE:SHARPIND · Textiles: yarn spinning · Analysis · 29 Oct 2026
Sharp Industries: a restarted cotton-yarn mill swung to a BDT 2.39 loss per share in FY2026 on negative gross margins and BDT 3bn of short-term debt
The 2023 merger with Samin Food & Beverage put 121,000 spindles back to work after the 2019 fire, but the mill ran at 58% of capacity, earned a thin spread, sold below cost in Q2 and Q3 FY2026, and moved to DSE's Z category on 25-Oct-2026 after a second year without a dividend.
Company · DSE:ORIONPHARM · Pharmaceuticals & healthcare · Analysis · 29 Oct 2026
Orion Pharma: power revenue fell 88% after the plant contracts expired, leaving a BDT 25.6bn debt load on a pharma business earning BDT 251m
FY2025 consolidated revenue fell 61.6% to BDT 4.08bn and the group lost BDT 415m. The auditor qualified its opinion over a restated UCB loan and a BDT 651m claim on an individual; the shares have been in DSE's Z category since 5-Feb-2025 over an unpaid dividend.